Preliminary results of the France LEADLESS study. A safety and effectiveness monitoring of a new ventricular leadless pacemaker.

Back

EHRA Premium Access

Preliminary results of the France LEADLESS study. A safety and effectiveness monitoring of a new ventricular leadless pacemaker.

Session: Pacing therapy

Topic: Antibradycardia Pacing

Speaker: Professor P. Defaye (Grenoble, FR)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Professor Pascal Defaye

CHU Grenoble, Grenoble (France)

25 presentations

1 follower

6 more presentations in this session

First european experience with a leadless atrial pacemaker

Speaker: Mr E. von Felten (Zurich, CH)

A higher pacing rate more effectively reduces central blood pressure in patients with sick sinus syndrome and hypertension

Speaker: Doctor S. Heinsar (Tallinn, EE)

Predictive factors of high burden of ventricular pacing in patients undergoing permanent pacemaker implantation after transcatheter aortic valve implantation

Speaker: Doctor C. Chaumont (Rouen, FR)

Correlation between manual and automatic measurements of the atrial signal in VDD leadless pacemakers (Micra AV)

Speaker: Doctor T. Van Weyenbergh (Leuven, BE)

one-year outcomes of the first 1000 patients implanted with th micra AV leadless pacing system in france: the AV-CESAR cohort study

Speaker: Doctor F. kerkouri (Brest, FR)

Access

Abstract

Slides

Access the full session

Pacing therapy

Speakers: Professor P. Defaye, Mr E. von Felten, Doctor S. Heinsar, Doctor C. Chaumont, Doctor T. Van Weyenbergh...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources